Verrica Pharmaceuticals, Inc. (VRCA)
4.11
-0.07
(-1.67%)
USD |
NASDAQ |
Oct 09, 16:00
4.10
-0.01
(-0.24%)
After-Hours: 20:00
Verrica Pharmaceuticals Shareholders Equity (Quarterly) : 4.307M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.307M |
| March 31, 2026 | 16.06M |
| December 31, 2025 | 24.74M |
| September 30, 2025 | -17.04M |
| June 30, 2025 | -17.48M |
| March 31, 2025 | -18.58M |
| December 31, 2024 | -9.86M |
| September 30, 2024 | -34.05M |
| June 30, 2024 | -13.30M |
| March 31, 2024 | 1.512M |
| December 31, 2023 | 19.76M |
| September 30, 2023 | 42.30M |
| June 30, 2023 | 55.40M |
| March 31, 2023 | 64.85M |
| December 31, 2022 | 40.03M |
| September 30, 2022 | 44.76M |
| June 30, 2022 | 16.33M |
| March 31, 2022 | 25.42M |
| Date | Value |
|---|---|
| December 31, 2021 | 32.60M |
| September 30, 2021 | 40.85M |
| June 30, 2021 | 52.16M |
| March 31, 2021 | 61.81M |
| December 31, 2020 | 32.99M |
| September 30, 2020 | 39.63M |
| June 30, 2020 | 48.46M |
| March 31, 2020 | 56.61M |
| December 31, 2019 | 65.42M |
| September 30, 2019 | 71.65M |
| June 30, 2019 | 76.84M |
| March 31, 2019 | 82.76M |
| December 31, 2018 | 89.43M |
| September 30, 2018 | 96.35M |
| June 30, 2018 | 101.59M |
| March 31, 2018 | 27.75M |
| December 31, 2017 | 8.467M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.02M |
| Total Liabilities (Quarterly) | 31.71M |
| Debt to Equity Ratio | 0.4202 |
| Current Ratio | 1.333 |
| Net Debt Paydown Yield | 7.73% |